Literature DB >> 6149265

Lesch-Nyhan syndrome, caffeine model: increase of purine and pyrimidine enzymes in rat brain.

M D Miñana, M Portolés, A Jordá, S Grisolía.   

Abstract

Rats ingesting high doses of caffeine reproduce the self-destructive behaviour observed in the Lesch-Nyhan syndrome. This syndrome includes a deficit in hypoxanthine-guanine phosphoribosyltransferase. We have observed, however, that the activity of hypoxanthine-guanine phosphoribosyltransferase increases in direct proportion to the concentration of caffeine found in rat brain. It appears, therefore, that the caffeine model is not a true model for the Lesch-Nyhan syndrome, or alternatively, that the deficit in hypoxanthine-guanine phosphoribosyltransferase is coincidental and not a main key to the multifarious aspects of the syndrome, particularly the self-mutilation. The possibility that levels of dopamine are increased in the caffeine model are discussed as a basis for the destructive behaviour. We have found also that ingestion of large amounts of caffeine increases the activities in rat brain of adenosine deaminase, purine nucleoside phosphorylase, aspartate carbamoyl-transferase, dihydroorotase, and dihydroorotate oxidase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149265     DOI: 10.1111/j.1471-4159.1984.tb06078.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

1.  Effect of caffeine on metabolism of L-arginine in the brain.

Authors:  Jelenka Nikolic; Gordana Bjelakovic; Ivana Stojanovic
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

2.  Caffeine-induced changes in the composition of the free amino acid pool of the cerebral cortex.

Authors:  M Portolés; M D Miñana; A Jordá; S Grisolía
Journal:  Neurochem Res       Date:  1985-07       Impact factor: 3.996

3.  Rats that consume caffeine show decreased brain protein synthesis.

Authors:  V Felipo; M Portolés; M D Miñana; S Grisolía
Journal:  Neurochem Res       Date:  1986-01       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.